Share data and analysis
Track the recent performance of Novartis shares on the SIX Swiss Exchange and Novartis American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE).
Local websites
General contact
Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Investors
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Media
Global Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
Reporting side effects
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
pane 4 content
Novartis country websites:
Novartis business websites:
Follow us
Novartis on Flickr
Stay up-to-date
© 2013 Novartis AG Terms of usePrivacy policy Sitemap